The 86th Annual Meeting of the Society of Tokyo Women\u27s Medical University\u27s Symposium on "Up-to-Date Robotic Surgery": Clinical Outcomes and Learning Curve of Robotic-Assisted Mitral Valve Plasty in Initial 100 Cases by 中村 喜次 & 新浪 博士
(シンポジウム「ロボット手術の最前線」)ロボット
支援下僧帽弁形成術の導入期成績















ナカムラ ヨシツグ ニイナミ ヒ ロ シ
中村 喜次１，２・新浪 博士２
（受理 2020年 12月 18日）
The 86th Annual Meeting of the Society of Tokyo Women’s Medical University’s
Symposium on“Up-to-Date Robotic Surgery”
Clinical Outcomes and Learning Curve of Robotic-Assisted Mitral Valve Plasty in Initial 100 Cases
Yoshitsugu Nakamura１，２ and Hiroshi Niinami２
１Department of Cardiovascular Surgery, Chibanishi General Hospital, Matsudo, Japan
２Department of Cardiovascular Surgery, Graduated School of Medicine, Tokyo Women’s Medical University, Tokyo, Japan
Background: Robotic-assisted mitral valve plasty (RMVP) was introduced in Japan in 2018. However, its clinical
outcomes and learning curve have not been fully discussed.
Objective: This study aimed to assess the clinical outcomes and learning curve of RMVP in its first 100 cases.
Methods: This study retrospectively analyzed the clinical records of 100 patients who underwent RMVP be-
tween June 2018 and October 2020.
Results: The mean age was 65±14 years, 46 patients were female, and the body surface area was 2.0±0.2. Euro-
SCORE II was 2.0±1.8. Thirty (30%) patients had New York Heart Association Class III or IV. The mean ejection
fraction was 61.7%±8.3%. Chronic heart failure occurred in 22 patients (22%). Diabetes medications were pre-
scribed in 13 patients (13%), and nine patients had infective endocarditis in (8 were healed and 1 was active). The
median operation, cardiopulmonary bypass, and aortic cross-clamp times were 236±47, 163±39, and 131±34
min, respectively. Concomitant procedures included maze (21%), left arterial appendage closure (32%), and patent
foramen ovale closure (5%). Repair techniques included the NeoChord technique (53%), leaflet resection/suture
(43%), edge-to-edge repair (18%), and folding plasty (24%). No in-hospital or 30-day mortality was recorded. Compli-
cations included reexploration (n=1, 1%), stroke (n=1, 3%), subarachnoid hemorrhage (n=1, 1%), postoperative
hemolysis (n=3, 3%). One patient required surgical re-intervention due to moderate mitral regurgitation (1%). On
echocardiography before discharge, the mitral regurgitation was graded as less than mild in 96 patients (96%).
The learning curves of the operation time, cardiopulmonary bypass time, and aortic cross-clamp time did not pla-
teau in 100 cases.
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Age, mean +/- SD 65 +/- 14
Male, n (%) 54 (54)
EuroSCORE II 2.0 +/- 1.8
Ejection fraction, mean +/- SD 61.7 +/- 8.3
NYHA III or IV, n (%) 30 (30)
Hypertention, n (%) 22 (22)
Diabetes, n (%) 13 (13)
Chronic kidney disease, n (%) 19 (19)
Infective endocarditis, n (%) 9 (9)
Active, n (%) 1 (1)
Healed, n (%) 8 (8)
Redo cardiotomy, n (%) 1 (1)
EuroSCORE, European System for Cardiac Oper-
ative Risk Evaluation; NYHA, New York Heart 
Association.
Conclusions: The clinical outcomes of the initial 100 cases of RMVP were satisfactory, but more than 100 cases
are required to achieve a stable operative time.






























た．術前リスク評価である平均 euroSCORE IIは 2.0





































Figure　2.　Postoperative surgical scar after robotic-assist-
ed mitral valve plasty.





















































Procedure success, n (%) 100 (100)
Conversion to sternotomy, n (%) 0 (0)
Concomitant procedure
maze, n (%) 21 (21)
Left atrial appendage closure, n (%) 32 (32)
Patent foramen ovale closure, n (%) 5 (5)
Repair technique
Neocord, n (%) 53 (53)
Resection and suture, n (%) 43 (43)
Edge to edge, n (%) 18 (18)
Folding, n (%) 24 (24)
Annuloplasty technique
Horizontal mattress suture, n (%) 52 (52)
Interruptted , n (%) 47 (47)
Type of annuloplasty band
Rigid, n (%) 32 (32)
Flexible, n (%) 68 (68)
Band size mean +/- SD, mm 30.5 +/- 2.2
Procedure time, mean +/- SD, min 236 +/- 47
Cardiopulmonary bypass time, mean +/- SD, min 169 +/- 39
Cross clamp time, mean +/- SD, min 131 +/- 34
Table　3.　Clinical outcomes.
Variables n=100
Mortolity, n (%) 100 (100)
Stroke, n (%) 0 (0)
Respiratory failure, n (%) 
Acute kidney failure, n (%) 21 (21)
Proxismal failure, n (%) 32 (32)
Reexplanation, n (%) 5 (5)
Reoperation, n (%) 
Hemolysis, n (%) 53 (53)
Postoperative MR <mild 43 (43)









































Figure　4.　Learning curve and trend line of the operation time.
Figure　5.　Learning curve and trend line of the cardiopulmonary bypass time.
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